信立泰：在深圳前海自贸区设立2200万元全资子公司

Core Viewpoint - The company has established a wholly-owned subsidiary in the Qianhai Free Trade Zone, Shenzhen, with a registered capital of up to 22 million yuan, focusing on human genetic diagnosis and treatment technology development [1] Group 1 - The board meeting was held in January 2026 to approve the establishment of the subsidiary [1] - The newly formed subsidiary is named Xinlitai Life Sciences (Shenzhen) Co., Ltd. and has completed its business registration [1] - The legal representative of the subsidiary is Xu Wenjie [1]